New pill aims to slow Alzheimer's decline
Disease control
Terminated
This study tested a twice-daily oral medication called varoglutamstat (PQ912) for people with early Alzheimer's disease. The goal was to see if the drug could safely slow the decline in memory and thinking skills. The trial was designed in two parts, starting with about 180 parti…
Phase: PHASE2 • Sponsor: Vivoryon Therapeutics N.V. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC